Thought Leaders and Key Opinion Leaders (KOLs)
November 15-16, 2004 Philadelphia, PA
Visit the conference website for more information and to register.
Key Opinion Leaders (KOLs) are crucial to the successful development and marketing of pharmaceutical products, yet historically programs for managing these critical relationships tend to be in the early stages and are inefficient. Recently pharmaceutical companies are seeing the importance of developing a company wide strategy for working with KOLs. This shift has increased the benefits seen from working with KOLs but also brought on an increase in scrutiny on relationships between pharmaceutical companies and KOLs.
CBIs Forum on Define Appropriate and Effective Interactions with Medical Advisors and Key Opinion Leaders (KOLs) provides a platform for clinical, medical affairs, MSLs and marketing to interact and discuss successful collaboration with KOLs throughout the product life cycle. Attend this conference and learn how to identify, profile and communicate with KOLs from the early stages of clinical trials to post marketing initiatives.
Key topics at this forum include: strategies to recruit and select top opinion leaders, incorporating thought leaders input into the development of an advocacy structure, ongoing issues and guidelines on interactions with KOLs, breaking the silo mentality between clinical operations, medical affairs and marketing, managing KOL expectations for the communication of data and much more!
Hear Presentations from these Leading Companies:
Abbott Laboratories * Amgen * AstraZeneca Pharmaceuticals* Genzyme Corporation LipoScience, Inc. * Novo Nordisk® Pharmaceuticals, Inc. * McNeil Consumer & Specialty Pharmaceuticals * Sanofi-Synthelabo Inc. * Sepracor